A Phase III, Randomized, Multi-Center, Open-Label, Active-Comparator Controlled Study To Evaluate the Efficacy and Safety of APL-2 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Administered By
Awarded By
Contributors
- de Castro III, Carlos Manuel Principal Investigator
Start/End
- January 15, 2019 - January 31, 2024